The whole saga surrounding Obamacare is contributing to the European pharmaceutical firms disappointing performance
Carax Alphavalue |The European pharmaceutical sector hit record highs almost two years ago, since when it has had an overall disappointing performance. So far this year, there has been no sign of its defensive qualities, although it continues to pay attractive dividends.